Addex Therapeutics Ltd (ADXN) — Capital Reinvestment Ratio
Addex Therapeutics Ltd (ADXN) has a Capital Reinvestment Ratio of 0.07x as of December 2020, meaning it reinvests 0% of its operating cash flow (CHF704.85K) in capital expenditures (CHF48.09K). See ADXN net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Addex Therapeutics Ltd Capital Reinvestment Ratio (2018–2018)
This chart tracks Addex Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. Check ADXN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Addex Therapeutics Ltd (2018–2018)
Year-by-year Capital Reinvestment Ratio for Addex Therapeutics Ltd from 2018 to 2018. For live market cap and broader valuation context, see market value of Addex Therapeutics Ltd.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.01x | CHF1.75 Million | CHF9.05K | — |